PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT VETERANS WITH INFLAMMATORY BOWEL DISEASE ON MAINTENANCE INFLIXIMAB

被引:0
|
作者
Pham, Codey
Xu, Anthony
Sansgiry, Shubhada
Waljee, Akbar K.
Hou, Jason K.
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Tu1788
引用
收藏
页码:S1128 / S1128
页数:1
相关论文
共 50 条
  • [1] PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Waljee, Akbar
    Hou, Jason
    INFLAMMATORY BOWEL DISEASES, 2023, 29 : S79 - S79
  • [2] PATTERNS OF STEROID USE AMONG A REAL-WORLD NATIONAL COHORT OF VETERANS WITH INFLAMMATORY BOWEL DISEASE
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Waljee, Akbar
    Hou, Jason
    GASTROENTEROLOGY, 2023, 164 (04) : S101 - S102
  • [3] BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH ADVERSE OUTCOMES: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL COHORT OF US MILITARY VETERANS WITH INFLAMMATORY BOWEL DISEASE
    Hou, Jason K.
    Pham, Codey
    Sansgiry, Shubhada
    Modi, Varsha
    Waljee, Akbar K.
    GASTROENTEROLOGY, 2023, 164 (06) : S645 - S646
  • [4] Biosimilar Infliximab Switching is Not Associated with Adverse Outcomes: A Real-World Effectiveness Analyses in a National US Cohort of US Military Veterans with Inflammatory Bowel Disease
    Hou, J. K.
    Pham, C.
    Sansgiry, S.
    Modi, V.
    Waljee, A. K.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 880 - 881
  • [5] MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL US COHORT
    Hou, Jason
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Modi, Varsha
    Waljee, Akbar
    GASTROENTEROLOGY, 2024, 166 (03) : S9 - S9
  • [6] MULTIPLE BIOSIMILAR INFLIXIMAB SWITCHING IS NOT ASSOCIATED WITH DISEASE FLARE IN INFLAMMATORY BOWEL DISEASE: A REAL-WORLD EFFECTIVENESS ANALYSES IN A NATIONAL US COHORT
    Hou, Jason
    Pham, Codey
    Xu, Anthony
    Sansgiry, Shubhada
    Modi, Varsha
    Waljee, Akbar
    INFLAMMATORY BOWEL DISEASES, 2024, 30 : S7 - S7
  • [7] Infliximab Biosimilar Use for Inflammatory Bowel Disease: A National Veterans Affairs Experience
    Johnson, Jessica
    Gawron, Andrew J.
    Curtis, Jeffrey R.
    Pinnell, Derek K.
    Chen, Wei
    Pei, Shaobo
    Rojas, Jorge, Jr.
    Baker, Joshua F.
    Sauer, Brian
    Star, Vicki
    Wu, David
    Walsh, Jessica A.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S389 - S390
  • [8] Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
    Gros, Beatriz
    Plevris, Nikolas
    Constantine-Cooke, Nathan
    Lyons, Mathew
    O'Hare, Claire
    Noble, Colin
    Arnott, Ian D.
    Jones, Gareth-Rhys
    Lees, Charlie W.
    Derikx, Lauranne A. A. P.
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2023, : 179 - 188
  • [9] MULTIPLE INFLIXIMAB BIOSIMILAR SWITCHES APPEAR TO BE SAFE AND EFFECTIVE IN A REAL-WORLD INFLAMMATORY BOWEL DISEASE COHORT
    Gros, Beatriz
    Plevris, Nikolas
    Constantine-Cooke, Nathan
    Lyons, Mathew
    O'Hare, Claire
    Noble, Colin L.
    Arnott, Ian
    Jones, Gareth-Rhys
    Lees, Charlie W.
    Derikx, Lauranne
    GASTROENTEROLOGY, 2023, 164 (06) : S94 - S95
  • [10] Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort
    Gros, B.
    Plevris, N.
    Constantine-Cooke, N.
    Lyons, M.
    O'Hare, C.
    Noble, C.
    Arnott, I. D.
    Jones, G. R.
    Lees, C. W.
    Derikx, L. A. A. P.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 876 - 876